HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Induction of vascular endothelial growth factor-A165a in human retinal and endothelial cells in response to glyoxal.

Abstract
Low-density lipoprotein (LDL) apheresis is effective and safe for patients with diabetes, proteinuria, and dyslipidemia. Diabetes mellitus is accompanied by ocular microvascular complications like retinal neovascularization or diabetic macular edema. These are leading causes of blindness and can be mediated by abnormal vessel growth and increased vascular permeability due to elevated levels of vascular endothelial growth factor (VEGF) in diabetic patients. In this study, we established methods to study the expression of different VEGF isoforms in human retinal and endothelial cells. The VEGF-A165a isoform is much higher expressed in retinal cells, compared to endothelial cells. Stimulation with glyoxal as a model of oxidative stress under diabetic conditions lead to a pronounced induction of VEGF-A165a in human retinal and endothelial cells. These data suggest that diabetes and oxidative stress induce VEGF-A isoforms which could be relevant in regulating the ingrowths of novel blood vessels into the retina in diabetic patients.
AuthorsHenning Morawietz, Annika Frenzel, Alice Mieting, Winfried Goettsch, Monika Valtink, Cora Roehlecke, József Jászai, Richard H W Funk, Klio A Becker, Katrin Engelmann
JournalTherapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (Ther Apher Dial) Vol. 26 Suppl 1 Pg. 29-34 (Dec 2022) ISSN: 1744-9987 [Electronic] Australia
PMID36468302 (Publication Type: Journal Article)
Copyright© 2022 The Authors. Therapeutic Apheresis and Dialysis published by John Wiley & Sons Australia, Ltd on behalf of International Society for Apheresis and Japanese Society for Apheresis.
Chemical References
  • Vascular Endothelial Growth Factor A
  • Glyoxal
  • Protein Isoforms
Topics
  • Humans
  • Vascular Endothelial Growth Factor A (metabolism)
  • Diabetic Retinopathy (therapy, etiology, metabolism)
  • Endothelial Cells (metabolism)
  • Glyoxal (pharmacology, metabolism)
  • Macular Edema
  • Retina (metabolism)
  • Protein Isoforms (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: